Restoration of Proliferative Response to M. leprae Antigens in Lepromatous T Cells Against Candidate Antileprosy Vaccines

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 64, Issue 3, 1996, Pages 257-267

  Mustafa, Abu Salim ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

LEPROSY VACCINE;

ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; INFECTION PREVENTION; LEPROMATOUS LEPROSY; MYCOBACTERIUM LEPRAE; T LYMPHOCYTE;

BACTERIAL PROTEINS; BACTERIAL VACCINES; CELLS, CULTURED; HUMANS; IMMUNITY, CELLULAR; LEPROSY; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM LEPRAE; RECOMBINANT PROTEINS; T-LYMPHOCYTES; VACCINES, ATTENUATED; VACCINES, COMBINED; VACCINES, INACTIVATED;

EID: 0029825307     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. BLOOM, B. and MEHRA, V. Immunological unresponsiveness in leprosy. Immunol. Rev. 80 (1984) 5-28.
2. CHAUDHURI, S., FOTEDAR, A. R. and TALWAR, G. P. Lepromin conversion in repeatedly lepromin negative BL/LL patients after immunization with autoclaved Mycobacterium w. Int. J. Lepr. 51 (1983) 159-168.
3. CONVIT, J., ARANZAZU, N., ULRICH, M., PINARDI, M. E., REYES, O. and ALVARADO, J. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda negative contacts. Int. J. Lepr. 50 (1982) 415-424.
4. CONVIT, J., ULRICH, M., ARANZAZU, N., CASTELLANOS, P. L., PINARDI, M. E. and REYES, O. The development of a vaccination model using two microorganisms and its application in leprosy and leishmaniasis. Lepr. Rev. 57 Suppl. 2 (1986) 263-273.
5. GILL, H. K. and GODAL, T. Deficiency of cell-mediated immunity in leprosy. Prog. Allergy 37 (1986) 377-390.
6. GILL, H. K., MUSTAFA, A. S. and GODAL, T. Induction of delayed-type hypersensitivity in human volunteers immunized with a candidate leprosy vaccine consisting of killed Mycobacterium leprae. Bull. WHO 64 (1986) 121-126.
7. GILL, H. K., MUSTAFA, A. S. and GODAL, T. In vitro proliferation of lymphocytes from human volunteers vaccinated with armadillo-derived killed M. leprae. Int. J. Lepr. 55 (1987) 30-35.
8. GILL, H. K., MUSTAFA, A. S. and GODAL, T. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction. Int. J. Lepr. 56 (1988) 36-44.
9. GILL, H. K., RIDLEY, D. S., GANESAN, J., MUSTAFA, A. S., REES, R. J. W. and GODAL, T. Mycobacterium leprae reactive T cell clones from lepromatous leprosy patients after prolonged chemotherapy. Lepr. Rev. 61 (1990) 25-31.
10. GULLE, H., SCHOEL, B., CHIPLUNKAR, S., GANGAL, S., DEO, M. G. and KAUFMANN, S. H. E. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae. Int. J. Lepr. 60 (1992) 44-53.
11. HAREGEWOIN, A., GODAL, T., MUSTAFA, A. S., BELEHU, A. and YEMANEBERHAN, T. T-cell conditioned media reverse T-cell unresponsiveness in lepromatous leprosy. Nature 303 (1983) 342-344.
12. HAREGEWOIN, A., LONGELY, J., MUSTAFA, A. S. and GODAL, T. The role of interleukin-2 in the specific unresponsiveness of lepromatous leprosy to Mycobacterium leprae; studies in vivo and in vitro. Immunol. Lett. 11 (1986) 249-252.
13. HAREGEWOIN, A., MUSTAFA, A. S., HELLE, I., WATERS, M. F. R., LEIKER, D. L. and GODAL, T. Reversal by interleukin-2 of the T-cell unresponsiveness of lepromatous leprosy to Mycobacterium leprae. Immunol. Rev. 80 (1984) 77-86.
14. KAPLAN, G., BRITTON, W. J., HANCOCK, G. E., THEUVENET, W. J., SMITH, K. A., JOB, C. K., ROCHE, P. W., MOLLOY, A., BURKHARDT, R., BARKER, J., PRADHAN, H. R. and COHN, Z. A. The systemic influence of recombinant interleukin-2 on the manifestations of lepromatous leprosy. J. Exp. Med. 173 (1991) 993-1006,
15. KAPLAN, G., KIESSLING, R. TEKLEMARIAM, S., HANCOCK, G., SHEFTEL, G., JOB, C. K., CONVERSE, P., OTTENHOFF, T. H. M., BECX-BLEUMINK, M., DEETZ, M. and COHN, Z. A. The reconstitution of cell-mediated immunity in the cutaneous lesions of lepromatous leprosy by recombinant interleukin-2. J. Exp. Med. 169 (1989) 893-907.
16. KATOCH, K., NATARAJAN, M., BAGGA, A. K., NARAYANA, R. B. and KATOCH, V. M. Immunotherapy of treated BL/LL cases with BCG: histopathological, immuhistological and bacteriological assessment. Acta Leprol. 7 Suppl. 1 (1989) 153-155.
17. KRZYCH, U., FOWLER, A. V. and SERCARZ, E. E. Repertoires of T cells directed against a large protein antigen, beta galactosidase. II. Only certain T helper or T suppressor cells are relevant in particular regulatory interactions. J. Exp. Med. 162 (1985) 311-323.
18. LAAL, S., BHUTANI, L. K. and NATH, I. Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum. Infect. Immun. 50 (1985) 887-892.
19. MUSTAFA, A. S. Identification of T-cell activating recombinant antigens shared among three candidate antileprosy vaccines, killed M. leprae, M. bovis BCG and Mycobacterium w. Int. J. Lepr. 50 (1988) 265-273.
20. MUSTAFA, A. S., GILL, H. K., NERLAND, A., BRITTON, W. J., MEHRA, V., BLOOM, B. R., YOUNG, R. A. and GODAL T. Human T cell clones recognize a major M. leprae antigen expressed in E. coli. Nature (London) 319 (1986) 63-66.
21. MUSTAFA, A. S. and GODAL, T. In vitro introduction of human suppressor T cells by mycobacterial agents. BCG activated OKT4+ cells mediate suppression of antigen-induced T cell proliferation. Clin. Exp. Immunol. 52 (1983) 29-37.
22. MUSTAFA, A. S. and GODAL T. BCG induced suppressor T cells optimal conditions for in vitro induction and mode of action. Clin. Exp. Immunol. 62 (1985) 474-481.
23. + cytotoxic T cells from BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in vitro. Clin. Exp. Immunol. 69 (1987) 255-262.
24. MUSTAFA, A. S., KVALHEIM, G., DEGRE, M. and GODAL, T. Mycobacterium bovis BCG induced human T cell clones from BCG vaccinated healthy subjects: antigen specificity and lymphokine production. Infect. Immun. 53 (1986) 491-497.
25. MUSTAFA, A. S., LUNDIN, K. E. A. and OFTUNG, F. Human T cells recognize mycobacterial heat shock proteins in the context of multiple HLA-DR molecules: studies with healthy subjects vaccinated with Mycobacterium bovis BCG and Mycobacterium leprae. Infect. Immun. 61 (1993) 5294-5301.
26. MUSTAFA, A. S. and OFTUNG, F. Long lasting T cell reactivity to Mycobacterium leprae antigens in human volunteers vaccinated with killed M. leprae. Vaccine 11 (1993) 1108-1112.
27. MUSTAFA, A. S., OFTUNG, F., DEGGERDAL, A., GILL, H. K., YOUNG, R. A. and GODAL, T. Gene isolation with human T lymphocyte probes. Isolation of a gene that expresses an epitope recognized by T cell specific for Mycobacterium bovis BCG and pathogenic mycobacteria. J. Immunol. 141 (1988) 2729-2733.
28. MUSTAFA, A. S., OFTUNG, F., GILL, H. K. and NATVIG, I. Characteristics of human T cell clones from BCG and killed M. leprae vaccinated subjects and tuberculosis patients. Lepr. Rev. 57 Suppl. 2 (1986) 123-130.
29. MUSTAFA, A. S. and TALWAR, G. P. Delayed hypersensitivity skin reactions to homologous and heterologous antigens in guinea-pigs immunized with M. leprae and four other selected cultivable mycobacterial strains. Lepr. India 50 (1978) 509-519.
30. MUSTAFA, A. S. and TALWAR, G. P. Early and late reactions in tuberculoid and lepromatous leprosy patients with lepromins from Mycobacteria leprae and five selected cultivable mycobacteria. Lepr. India 50 (1978) 566-571.
31. MUTIS, T., CORNELISSE, Y. E., DATEMA, G., VAN DEN ELSEN, P. J., OTTENHOFF, T. H. M. and DEVRIES, R. R. P. Definition of a human suppressor T cell epitope. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9456-9460.
32. NATARAJAN, M., KATOCH, K. GABBA, A. K. and KATOCH, V. M. Histological changes with combined chemotherapy and immunotherapy in highly bacillated lepromatous leprosy. Acta Leprol. 8 (1992) 79-86.
33. NOGUEIRA, N., KAPLAN, G., LEVY, E., SARNO, E. N., KUSHNER, P., GRANELLI-PIPERNO, A., VIEIRA, L., COLOMER-GOULD, V., LEVIS, W. R., STEINMAN, R., YIP, Y. K. and COHN, Z. A. Defective γ-interferon production in leprosy; reversal with antigen and interleukin-2. J. Exp. Med. 158 (1983) 2165-2170.
34. OFTUNG, F., MUSTAFA, A. S., HUSSON, R., YOUNG, R. A. and GODAL, T. Human T cell clones recognize two abundant Mycobacterium tuberculosis protein antigens expressed in Escherichia coli. J. Immunol. 138 (1987) 927-931.
35. OFTUNG, F., MUSTAFA, A. S., SHINNICK, T. M., HOUGHTON, R. A., KVALHEIM, G., DEGRE, M., LUNDIN, K. E. A. and GODAL, T. Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells. J. Immunol. 141 (1988) 2749-2754.
36. OTTENHOFF, T. H. M., CONVERSE, P. J., GEBRE, N., WONDIMU, A., EHRENBERG, J. P. and KIESSLING, R. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous non-responder defect can be overcome in vitro by stimulation with fractionated M. leprae components. Eur. J. Immunol. 19 (1989) 707-713.
37. OTTENHOFF, T. H. M., ELFERINK, D. G., KLATSER, P. R. and DE VRIES, R. R. P. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature 322 (1986) 462-464.
38. RADA, E., ULRICH, M., ARANZAZU, N., SANTAELLA, C., GALLINOTO, M., CENTENO, M., RODRIGUEZ, V. and CONVIT, J. A longitudinal study of immunological reactivity in leprosy patients treated with immunotherapy. Int. J. Lepr. 62 (1994) 552-558.
39. RIDLEY, D. S. and JOPLING, W. H. Classification of leprosy according to immunity; a five-group system. Int. J. Lepr. 34 (1966) 255-273.
40. WICKER, L. S., KATZ, M., SERCARZ, E. E. and MILLER, A. Immunodominant protein epitopes. I. Induction of suppression to hen egg white lysozyme is obliterated by removal of the first three N-terminal amino acids. Eur. J. Immunol. 14 (1984) 442-447.
41. YADAV, A., SURESH, N. R., ZAHEER, S. A., TALWAR, G. P. and MUKHERJEE, R. T cell responses to fractionated antigens of Mycobacterium w, a candidate anti-leprosy vaccine, in leprosy patients. Scand. J. Immunol. 34 (1991) 23-31.
42. YOUNG, R. A., BLOOM, B. R., GROSSKINSKY, C. M., IVANYI, J., THOMAS, D. and DAVIS, R. W. Detection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 2583-2587.
43. YOUNG, R. A., MEHRA, V., SWEETSER, D., BUCHANAN, T., CLARK-CURTISS, J., DAVIS, R. W. and BLOOM, B. R. Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature (London) 316 (1985) 450-452.
44. ZAHEER, S. A., MUKHERJEE, A., RAMESH, V., MISRA, R. S., KAR, H. K., SHARMA, A. K., BEENA, K. R., WALIA, R., MUKHERJEE, R., KAUR, H. and TALWAR, G. P. Immunotherapy benefits multibacillary leprosy patients with persistently high bacteriological index despite long-term multidrug therapy. Immunol. Infect. Dis. 5 (1995) 115-122.
45. ZAHEER, S. A., MUKHERJEE, R., RAMKUMAR, B., MISRA, R. S., SHARMA, A. K., KAR, H. K., KAUR, H., NAIR, S., MUKHERJEE, A. and TALWAR, G. P. Combined multidrug and Mycobacterium w vaccine therapy in patients with multibacillary leprosy. J. Infect. Dis. 167 (1993) 401-410.